ITGAX and adenoma: Quantitative analysis of CD11c+ (also known as ITGAX+) stromal immature macrophage lineage cells (IMCs) and surfactant protein-C (SPC+; also known as SFTPC+) adenoma cells using flow cytometry (Kamata et al., 2015, 2020) confirmed that both cell types were robustly decreased by atorvastatin treatment (Fig. 1D).